causal

Molecule Design Is Not the Real Bottleneck

The idea that drug discovery is rate-limited by the ability to design molecules is not really true; the actual rate limit is downstream clinical development and testing, including gathering the evidence needed to justify approval and marketing.

causalpending

Speaker

Alex

Evidence Quote

“Our ability is much more rate limited by the downstream clinical development and testing these drugs and gathering information.”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...